Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial.

Ian Judson; Jaap Verweij; Hans Gelderblom; J?rg T Hartmann; Patrick Sch?ffski; Jean-Yves Blay; J Martijn Kerst; Josef Sufliarsky; Jeremy Whelan; Peter Hohenberger; Anders Krarup-Hansen; Thierry Alcindor; Sandrine Marreaud; Saskia Litière; Catherine Hermans; Cyril Fisher; Pancras C W Hogendoorn; A Paolo dei Tos; Winette T A van der Graaf

首页> 外文期刊>The lancet oncology >Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial.

【24h】

Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial.

机译：单用阿霉素与强化阿霉素加异环磷酰胺一线治疗晚期或转移性软组织肉瘤：一项随机对照3期试验。

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Cancer Research UK, EORTC Charitable Trust, UK NHS, Canadian Cancer Society Research Institute, Amgen.

机译：英国癌症研究中心，EORTC慈善信托基金，英国国家医疗服务系统，加拿大癌症协会研究院，安进。

著录项

来源
《The lancet oncology》 |2014年第4期|共9页
作者
Ian Judson; Jaap Verweij; Hans Gelderblom; J?rg T Hartmann; Patrick Sch?ffski; Jean-Yves Blay; J Martijn Kerst; Josef Sufliarsky; Jeremy Whelan; Peter Hohenberger; Anders Krarup-Hansen; Thierry Alcindor; Sandrine Marreaud; Saskia Litière; Catherine Hermans; Cyril Fisher; Pancras C W Hogendoorn; A Paolo dei Tos; Winette T A van der Graaf;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial. [J] . Ian Judson, Jaap Verweij, Hans Gelderblom, The lancet oncology . 2014,第4期

机译：单用阿霉素与强化阿霉素加异环磷酰胺一线治疗晚期或转移性软组织肉瘤：一项随机对照3期试验。
2. Doxorubicin plus evofosfamide versus doxorubicin alone in locally advanced, unresectable or metastatic soft-tissue sarcoma (TH CR-406/SARC021): an international, multicentre, open-label, randomised phase 3 trial (vol 18, pg 1089, 2017) [J] . Tap W. D., Papai Z., Van Tine B. A. The lancet oncology . 2018,第2期

机译：Doxorubicin Plus evofosfamide与多柔比霉素单独在局部先进，不可切除或转移性组织Sarcoma（Th CR-406 / SARC021）：国际，多期中心，开放标签，随机阶段3试验（Vol 18，PG 1089,2017）
3. Doxorubicin plus evofosfamide versus doxorubicin alone in locally advanced, unresectable or metastatic soft-tissue sarcoma (TH CR-406/SARC021): an international, multicentre, open-label, randomised phase 3 trial [J] . Tap William D., Papai Zsuzsanna, Van Tine Brian A., The lancet oncology . 2017,第8期

机译：Doxorubicin Plus evofosfamide与多柔比蛋白单独在局部先进，不可切除或转移软组织Sarcoma（Th CR-406 / SARC021）：国际，多方形，开放标签，随机阶段3试验
4. PHASE III COMPARISON OF CARBOPLATIN VERSUS CARBOPLATIN AND DOXORUBICIN FOR THE ADJUVANT TREATMENT OF APPENDICULAR OSTEOSARCOMA: INTERIM ANALYSIS [C] . Katherine Skorupski, Justin Uhl, Stephen Shaw, Annual Conference of the Veterinary Cancer Society . 2009

机译：Carboplatin与Carboplatin和多柔比星的相位III比较，用于辅助骨肉瘤的佐剂治疗：临时分析
5. Cost effectiveness of liposomal doxorubicin versus paclitaxel for the treatment of advanced AIDS-related Kaposis Sarcoma. [D] . Raimundo, Karina Pupio. 2011

机译：脂质体阿霉素与紫杉醇在治疗晚期艾滋病相关的卡波西斯肉瘤中的成本效益。
6. Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial [O] . Beatrice Seddon, Sandra J Strauss, Jeremy Whelan, -1

机译：吉西他滨和多西他赛与阿霉素相比在先前未经治疗的晚期不可切除或转移性软组织肉瘤（GeDDiS）中作为一线治疗：一项随机对照的3期试验
7. Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial. [O] . Seddon B., Strauss S.J., Whelan J., 2017

机译：吉西他滨和多西紫杉醇与多柔比星作为先前未治疗的晚期不可切除或转移性软组织肉瘤（GeDDis）的一线治疗：随机对照3期试验。

Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial.

摘要

著录项

相似文献

相关主题

期刊订阅